Journal Article

Protective Effects of Sodium Copper Chlorophyllin and/or Ascorbic Acid Against Barium Chloride-Induced Oxidative Stress in Mouse Brain and Liver

Limami, Youness, Abboussi, Oualid, Rabbaa, Soufiane, El Attar, Hicham, Benabdelkhalek, Bouchra, Duval, Raphaël Emmanuel, Laaziouez, Yassir, Amahdar, Loubna, El Kebbaj, Riad, Benayad, Salma, Bouchab, Habiba, Wahnou, Hicham, Es-Sai, Basma

2025

Overview

Barium chloride (BaCl2), a known environmental pollutant, induces organ-specific oxidative stress through disruption of redox homeostasis. This study evaluated the protective effects and safety profile of sodium copper chlorophyllin (SCC) and ascorbic acid (ASC) against BaCl2-induced oxidative damage in the liver and brain of mice using a two-phase experimental protocol. Animals received either SCC (40 mg/kg), ASC (160 mg/kg), or their combination for 14 days prior to BaCl2 exposure (150 mg/L in drinking water for 7 days), allowing evaluation of both preventive and therapeutic effects. Toxicological and behavioral assessments confirmed the absence of systemic toxicity or neurobehavioral alterations following supplementation. Body weight, liver and kidney indices, and biochemical markers (Aspartate Aminotransferase (ASAT), Alanine Aminotransferase (ALAT), creatinine) remained within physiological ranges, and no anxiogenic or locomotor effects were observed. In the brain, BaCl2 exposure significantly increased SOD (+49%), CAT (+66%), GPx (+24%), and GSH (+26%) compared to controls, reflecting a robust compensatory antioxidant response. Although lipid peroxidation (MDA) showed a non-significant increase, SCC, ASC, and their combination reduced MDA levels by 42%, 37%, and 55%, respectively. These treatments normalized antioxidant enzyme activities and GSH, indicating an effective neuroprotective effect. In contrast, the liver exhibited a different oxidative profile. BaCl2 exposure increased MDA levels by 80% and GSH by 34%, with no activation of SOD, CAT, or GPx. Histological analysis revealed extensive hepatocellular necrosis, vacuolization, and inflammatory infiltration. SCC significantly reduced hepatic MDA by 39% and preserved tissue architecture, while ASC alone or combined with SCC exacerbated inflammation and depleted hepatic GSH by 71% and 78%, respectively, relative to BaCl2-exposed controls. Collectively, these results highlight a differential, organ-specific response to BaCl2-induced oxidative stress and the therapeutic potential of SCC and ASC. SCC emerged as a safer and more effective agent, particularly in hepatic protection, while both antioxidants demonstrated neuroprotective effects when used individually or in combination.

• Publisher: MDPI AG,MDPI
• Subject: Animals / Antioxidants / Antioxidants - pharmacology / ascorbic acid / Ascorbic Acid - pharmacology / Barium / barium chloride / Barium Compounds - adverse effects / Barium Compounds - toxicity / brain / Brain - drug effects / Brain - metabolism / Chlorides - adverse effects / Chlorides - toxicity / Chlorophyll / Chlorophyllides - pharmacology / Copper / Creatinine / Heavy metals / Life Sciences / Lipid peroxidation / Lipid Peroxidation - drug effects / Liver / Liver - drug effects / Liver - metabolism / Liver - pathology / Male / Metabolism / Mice / Oxidative stress / Oxidative Stress - drug effects / Pharmaceutical sciences / Physiology / Protective Agents - pharmacology / Reactive oxygen species / sodium copper chlorophyllin